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SENSITIVITY of the bladder epithelium to carcinogenic stimuli was demon-
trated by the induction of cancer following the introduction of coal tar directly
intothe bladders ofrats (Maisin and Picard, 1924; Picard, 1927). Bonser, Clayson,
Jull and Pyrah (1953) showed that the implantation of relatively large paraffin
wax pellets without added chemicals into the bladders of rats induced papillomas.
On the other hand Rudali, Chalvet and Winternitz (1955) were unable to obtain
tumours when small pellets of paraffin wax or cholesterol were inserted into the
bladders of rats, but carcinomata were produced with wax or cholesterol pellets
containing phenazine, 1: 2-5: 6-dibenzphenazine or 20-methylcholanthrene.
The bladders of mice seem to be more resistant to the apparent carcinogenic;
action of inert solids than are those of rats so that mice are more suitable animals
for the testing of bladder carcinogens.
Jull (1951) developed the technique of surgical introduction of wax pellets
containing carcinogens into the bladders of mice and this has been used very
effectively by Bonser, Clayson and Jull (1951) and by Bonser, Clayson, Jull and
Pyrah (1952) in studying the induction of bladder cancer. These authors found
that 2-naphthylamine, which induces bladder cancer in dogs and man, does not
cause cancer when introduced into the bladders of mice. On the other hand
pellets containing 2-amino-l-naphthol, which is a known intermediary metabolite
of 2-naphthylamine, produced cancer of the bladder. Thus they showed that
the method could give some indication as to whether a carcinogen was acting
directly or after metabolic changes. The fact that bladder tumours were obtained
with 20-methylcholanthrene and 3: 4-5: 6-dibenzcarbazole suggests that these
polycyclic compounds act without undergoing previous metabolic changes.
In the present work the technique described by Jull (1951) has been modified
in two ways (cf. Boyland and Watson, 1956). Firstly, the substances under test
are mixed with four parts of cholesterol and compressed into pellets instead of
being mixed with molten wax. Secondly, the opening in the bladder through
which the pellet is introduced is tied off with thread instead of being sewn. A
disadvantage of this method is that some tumours are induced by cholesterol
pellets alone and this must be considered in assessing the carcinogenicity of the
substances tested. Bonser, Bradshaw, Clayson and Jull (1956), in a thorough
investigation of this technique, obtained tumours in a proportion of mice treated
with pellets ofparaffin wax. This induction of cancer by chemically inert material
is perhaps analogous to the induction of sarcomata by subcutaneous implantation
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of chemically inert plastic materials observed by Oppenheimer, Oppenheimer,
Danishefsky, Stout and Eirich (1955).
The drawback to this method is similar to that encountered in investigationof
cocarcinogenesis with croton oil. Although treatment with croton oil without
aninitiatorgives some tumours inmice, the activity ofan initiator canbe estimated
by the increase in the tumour incidence after treatment with an initiator.
As already mentioned, the implantation of pellets of paraffin wax weighing
between 80 and 170 mg. inducespapillomas (Bonser et al., 1953), but the implanta-
tion of 10 mg. pellets did not do so (Rudali et al., 1955). It is probable therefore
that the implantation of pellets smaller than 10 mg. (e.g. 5 mg.) would induce
fewer tumours in the control mice.
Thistechnique has been used in the present communication in order to test the
following groups of compounds:
(1) Miscellaneous compounds.
(2) 1 : 2-5: 6-Dibenzanthracene, 1: 2-5: 6-dibenzanthracene-3: 4-quinone and
a metabolite 2-phenylphenanthrene-3-2'-dicarboxylic acid which Bhargava,
Hadler and Heidelberger (1955) consider to be the active carcinogenic metabolite
of the hydrocarbon.
(3) Metabolites and other derivatives of 2-naphthylamine.
(4) ortho Aminophenols derived from other carcinogenic aromatic amines
and related compounds.
(5) Metabolites of tryptophan some of which are ortho aminophenols and so
related to the metabolites of some carcinogenic aromatic amines.
In studying the metabolism of 2-naphthylamine in rats and rabbits 16 meta-
bolites (Table I) of the amine have been detected, but free 2-amino-1-naphthol
has not been found in freshly excreted urine (Boyland and Manson, 1955, 1957;
Boyland, Manson and Orr, 1957). Five of these metabolites have been tested in
the present work.
One of the metabolites is 2-amino-l-naphthol sulphuric ester which Bonser,
Bradshaw, Clayson and Jull (1956) have found to be non-carcinogenic by the
technique of bladder implantation. Human and animal urines contain arylsul-
phatases which might have been expected to liberate the carcinogenic 2-amino-
l-naphthol from the sulphuric ester. An examination of the action ofsulphatases
on sulphuric esters of aminophenols (Boyland, Manson, Sims and Williams,
1956) however, showed that 2-amino-l-naphthol sulphuric ester and other
sulphuric esters of o-aminophenols derived from carcinogenic amines were not
hydrolysed by sulphatase. This resistance of the sulphuric ester to enzymic
hydrolysis explains the lack of carcinogenicity of this metabolite.
EXPERIMENTAL
(1) Pellets weighing between 8 and 12 mg. were made up from a molten mixture
of 4 parts paraffin wax (m.p. 56°, filtered, from G. T. Gurr, Ltd.) and 1 part of
suspected carcinogen as described by Jull (1951).
(2) Pellets weighing between 9 and 11 mg. were prepared from a mixture of
4 parts cholesterol (Roche Products) and 1 part suspected carcinogen ground
together and compressed in a tablet-making machine.
The same samples of paraffin wax and cholesterol were used throughout the
experiments.
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TABLE I
Metabolites of 2-naphthylamine
1. 2-Amino-l-naphthol sulphuric ester.
2. 2-Acetamidonaphthalene.
3. 2-Naphthyl sulphamic acid.
4. 2-Naphthylamine-N-glucosiduronic acid.
5. 2-Amino-l-naphthol glucosiduronic acid.
6. 2-Amino-l-naphthol sulphuric ester N-gluco-
siduronic acid.
7. 2-Amino-6-naphthol.
8. 2-Acetamido-6-naphthol.
Ov Y NHCOCH3
cXy ,NHSO3H
cXf-NHC6H90°6
IC6H906
eON H2
HONcOCH3
NHCOCH3.
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TABLE I-cont.
9. 2-Aniino-6-naphthol sulphuric ester.
10. 2-Amnino-6-naphthyl glueosiduronic acid.
11. 2-Acetamido-6-naphthyl glucosiduronic acid.
12. 2-Acetamido-6-naphthlol sulphuric ester.
13. 2 - Acetamido - 5 6 - dihydroxy - 5: 6 - dihydro-
naphthalene.
14. 2 - Acetamido - 5 6 - dihydroxy - 5: 6 - dihydro-
naphthalene glucosiduronic acid.
15. 2 - Acetamido - 5: 6 - dihyrdoxynaphthalene sul-
phuric ester.
r,NrrH~r NH2
HO3SO
NH~~~ 2
06 H9C60NH2
c69, 0 NHCOCH3
06H9C6O
H SO~ "NHCOCH3
HO3 So
,NHCUCH3
NHCOCH3
HO3NHCOCH3
HO55
16. 2 - Acetamido - 5 : 6 - dihydroxynaphthalene
glucosiduronic acid.
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1: 2-5: 6-Dibenzanthracene, 3: 4-quinone and 2-phenylphenanthrane-3: 2'-
dicarboxylic acid were prepared as described by Bhargava, Hadler and Heidel-
berger (1955).
2-Amino-l-naphthol, 4-dimethylamino-3-hydroxydiphenyl, and 1-dimethyl-
amino-2-naphthol were prepared by hydrolysis ofthe sulphuric esters obtained by
oxidation of the parent amines with persulphate as described by Boyland and
Sims, (1954). Potassium 2-naphthylsulphamate and ammonium 2-.naphthylamine-
N-glucosiduronate were prepared by the methods of Boyland, Manson and Orr
(1957). 2-Amino1-naphtholglucosiduronicacidwas.preparedbytheacidhydrolysis
of 2-acetamido-1-naphthol glucosiduronic acid which was isolated from urine of
rabbits dosed with 2-acetamido-l-naphthol (Boyland and Manson, 1957).
3-Hydroxykynurenine was synthesised according to the method of Butenandt
and Hellmann (1950).
Stock mice were anaesthetised with a mixture of 90 per cent ether and 10 per
cent ethanol and maintained in anaesthesia by placing the head in a tube contain-
ing a cotton wool plug moistened with the anaesthetic. The abdominal wall was
wetted with ethanol and an incision made with scissors to give access to the
bladder. The apex of the bladder was held in forceps and a 3 mm. incision made
in the fundus with scissors (Fig. la). The pellet, held in straight forceps, was then
inserted into the bladder while the lumen was held open with 3 pairs of forceps
(Fig. lb). The suture was then held together with forceps and ligated close to the
forceps with a single fine silk ligature (Fig. lc). The abdominal wall was closed
by sewing in two layers using a figure-of-eight stitch.
The mice were returned to their cages and maintained on a mixed diet. Any
mice which appeared ill were killed, other mice were killed either at 40 weeks or
52 weeks after operation. All mice were examined at post mortem in a manner
previously described by Jull (1951). The bladders were distended by the injection
ofBouin's solution and fixed for 24 hours before they were cut open and examined
with a hand lens.
Selectedmaterialwasthenremovedforsectioning and microscopicexamination
from each mouse, and the various pathological lesions were diagnosed and placed
in one or other ofthe three following groups as advised by Bonser and Jull (1956).
1. Inflammatory lesions.-These were very common and consisted usually
of a dense infiltration of the mucosa with inflammatory cells of the lymphoid
type resulting often in a general thickening ofall coats ofthe bladder. These were
of no significance in relation to neoplastic changes.
2. Lesions due to operative trauma.-These consisted of small fibrous nodules
or islands of misplaced epithelium, sometimes forming small cysts. Lesions
associated with the sequestration of epithelium on the suture line had to be
distinguished from invasive neoplasms.
3. Neoplastic lesions.-Minute foci of epithelial hyperplasia were not regarded
as of neoplastic significance because although some may represent the earliest
presence of neoplasm others may be inflammatory in nature. The only lesions
recorded were larger nodules worthy of being called " tumours ", which projected
from the surface or dipped into the subepithelial tissues. These were classified
as either (a) benign papilloma and "adenoma" or (b) carcinoma. The distinction
between these two stages in neoplastic proliferation is not always easy because
there may be no hard and fast line of distinction between them. Benign tumours
according to their general cellular structure were called either "papillomas"INDUCED CANCER OF BLADDER IN MICE
1,(
lb Ic
FIG. 1.- -Stages in the process of introducing a pellet into the urinary
bladder of a mouse. (Diagrammatic.)
or "adenomas "provided there was no invasive infiltration, or cytological evidence
of malignancy. The term "carcinoma" was only used for tumours that were
invasive or had the histological characteristics ofmalignancy.
RESULTS
In most of the groups, 60 to 80 per cent of the mice survived the operation
for 30 weeks (Table II). When considering the reports recorded in the table,
papillomata, adenomata or carcinomata are all classified as " tumours" and the
activity of the compounds onsidered from the total incidence of " tumours ".
The presence of hyperplasia is not recorded. Among the mice which died in less
than 30 weeks after operation no tumours were seen, but in many cases post
mortem changes were so great that a histological diagnosis could not be made.
The "activity" is therefore considered from the ratio of number of tumour-
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bearing mice to the number of mice surviving for 30 weeks. The probability that
this ratio differed from the incidence in the control series was calculated by the
x2 test.
Although no tumours were seen in the 13 mice which survived for 30 weeks
or more after treatment with paraffin wax pellets, one mouse killed after 52
weeks showed hyperplastic changes of the bladder epithelium. Of the 24 mice
surviving 30 weeks or more after implantation with cholesterol pellets one had
a carcinoma and another mouse revealed hyperplastic changes. Thus the control
treatment does not produce a completely negative result. Ofthe 26 groups of mice
treatedwithsubstancesunder test, 9contained one tumour ineachgroup and except
for the 3-hydroxy-4-aminodiphenyl group in which only 10 mice survived 30
weeks the substances implanted in these groups may be considered as inactive.
These include:
1: 2-5: 6-Dibenzanthracene-3: 4-quinone
2-Phenylphenanthrene-3: 2'-dicarboxylic acid
Potassium 2-naphthylsulphamate
Ammonium-2-naphthylamine-N-glucosiduronate
2-Amino-6-naphthol hydrochloride
2-Acetamido-6-naphthol
1-Dimethylamino-2-naphthol,
4-Dimethylaminoazobenzene.
Examples of the lesions produced are illustrated in Fig. 3-8.
DISCUSSION
The technique of implanting pellets into the bladders of mice can be used to
indicate whether the carcinogenic activity is due to the substance itself or to a
metabolite, because the possibilities of metabolic changes occurring in the bladder
are limited. The present results are considered under five headings, three ofwhich
are concerned with theproblems ofthe roleofmetabolism ofcarcinogens inrelation
to their biological action.
1. Miscellaneous substances
Maleic hydrazide was tested in the present experiments because Darlington
and McLeish (1951) had found it to be a mitotic poison for plant cells. It did not
induce cancer in the bladder and this is in agreement with the findings of Barnes
and Haddow (personal communication) who did not obtain a significant incidence
oftumours in rats injected with this compound. Although itproduced chromosome
damage in plant cells, it does not interfere with mitosis in cells of the Walker carci-
noma, when injected into tumour-bearing rats (Boyland and Koller, unpublished
observations).
Pellets containing xanthine induced carcinomata. This is in agreement with
earlier work (Haddow, personal communication) in which injection of xanthine
induced sarcomata in rats.
Pellets containing saccharin induced a significant incidence ofbladder tumours.
On the other hand, in an experiment in which 20 mice were injected twice weekly
with 1 g. saccharin per kg. body weight for 12 weeks, no tumours developed,
although 12 mice lived for one year and 8 mice were killed 2 years after the
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Formulae A
commencement of the experiment. The bladders of these mice were examined
post-mortem as in the bladder implantation experiments. In further experiments
carried out with Professor P. C. Koller, the injection of 1 g. per kg. of saccharin
as the sodium salt into rats bearing the Walker Carcinoma produced no apparent
chromosome damage. Fitzhugh, Nelson and Frawley (1951) noticed that feeding
of saccharin to rats was associated with "an increased incidence of the ordinarily
uncommon condition of abdominal lymphosarcoma" but these authors did not
consider that saccharin was carcinogenic. Salaman and Roe (1956) found that
saccharin had some initiating action, that is, it caused skin tumours to appear
in mice when its application was followed by treatment with croton oil. The
induction of bladder tumours with saccharin suggests that the presence ofthe solid
pellet in the bladder may have a promoting action and that the method of bladder
implantation detects incomplete carcinogens.
2. 1: 2-5: 6-Dibenzanthracene and derivatives
Bladder tumours were produced with 1: 2-5:6-dibenzanthracene but the
oxidation product 1: 2-5: 6-dibenzanthracene-3: 4-quinone and the metabolite
2-phenylphenanthrene-3: 2'-dicarboxylic acid gave negative results. The parent
compound thus appears to initiate a neoplastic change without biochemical
elaboration. If this is the case, then the conversion of 1 :2-5: 6-dibenzanthracene
into 2-phenylphenanthrene-3: 2'-dicarboxylic acid described by Bhargava et
al. (1955) if of the nature of a side reaction or detoxication process. The possi-
bility remains that the phenylphenanthrene dicarboxylic acid cannot penetrate
into cells, but can be produced by metabolism of 1: 2-5: 6-dibenzanthracene
: 2-5: 6 Dibenzanthracene 1: 2-5: 6 Dibenza.nthracene 2-Phenylphenanthrene
3: 4-quinone 3: 2'-dicarboxylic acid
Formulae B-Hydrocarbon derivatives
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after the latter has entered susceptible cells. The simpler explanation is, however,
that the carcinogenic hydrocarbons are carcinogenic per se. The carcinogenic
action of hydrocarbons could be due to their ability to form complexes with the
purines of nucleic acid and "this association may change the nucleic acid suffici-
ently for chromosome aberrations to result" (Boyland, 1952). The induction of
tumours with the hydrocarbon is in agreement with the findings that the polycyclic
compounds 20-methylcholanthrene and 3: 4-5: 6-dibenzcarbazole are carcino-
genic in the mouse bladder (Bonser, Clayson, Jull and Pyrah, 1952).
3. Derivatives of 2-naphthylamine
Unlike 1: 2-5: 6-dibenzanthracene, some aromatic amines appear to be indirect
carcinogens which must be metabolised into active forms. 2-Naphthylamine
itself possesses only very slight activity as a bladder carcinogen but 2-amino-1-
naphthol is active (Bonser, Bradshaw, Clayson and Jull, 1956) and of the seven
derivatives examined only 2-amino-1-naphthyl glucosiduronic acid produced a
significant incidenced of tumours. It had been argued (Boyland and Manson,
1955; Boyland, 1956) that of the 16 identified metabolites of 2-naphthylamine
listed in Table I only one-2-amino-1-naphthyl glucosiduronic acid-should be
carcinogenic and this compound has now been shown to induce tumours. The
relatively high proportion of papillomas (4 papillomas, 3 carcinomas) induced
with this metabolite is remarkable. Ifone assumes that thepapillomas would have
developed into carcinomas in time then this finding suggests that the substance is
slow in action.
The insignificant incidence of tumours induced with 2-amino-6-naphthol
hydrochloride an 2-acetamido-6-naphthol is ofinterest as these are representatives
of the type of oxidation product in which the oxygen has entered the benzene
ring remote from the amino group. The inactivity of these substances makes it
improbable that derivatives of these (e.g., Nos. 9, 10, 11 and 12 of Table I)
would be carcinogenic but nevertheless they are being tested in experiments
which are now in progress. The inactivity of 2-amino-6-naphthol compared with
the activity of 2-amino-1-naphthol which is an ortho aminophenol is in agreement
with the idea that the carcinogenic activity ofsome at least ofthe aromatic amines
is dependent on their metabolic conversion to ortho aminophenols. The suscepti-
bility of the dog and man to the carcinogenic effect of 2-naphthylamine is
probably related to the relatively high proportion of 2-amino-l-naphthol formed
in vivo by these species. In rodents, which are more resistant to 2-naphthylamine,
derivatives of 2-amino-6-naphthol appear to be the predominant metabolites
(Clayson, 1953). 2-Amino-l-naphthol, however, does not usually occur free in
the urine but conjugated with glucuronic acid and sulphuric acid. In the
presence of f8-glucuronidase the glucosiduronate may be hydrolysed, liberating
the active compound. In the present experiment, 2-amino-1-naphthol glucosi-
duronic acid produced more tumours than did the free 2-amino-1-naphthol;
possibly because the carcinogenic activity of the latter was in part masked by
toxic effects. When the pellet of 2-amino-1-naphthol in cholesterol was inserted
into the bladder, a dose toxic to proliferating cells mnight have been introduced,
whereas in the case of the glucuronic acid conjugate, the free carcinogen would be
liberated slowly by fi-glucuronidase in the urine.
Bonser et al. (1956) has shown that 1-amino-2-naphthol and also 2-amino-1-
naphthol were carcinogenic in the bladder of mice. Our results suggest that the
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substitution of the amino group as in 1-dimnethylamino-2-naphthol destroyed the
activity. This is surprising as usually methylation of carcinogenic aromatic
amines either in the amino group itself or in the positions ortho to the amino grotup
enhantces their carcinogenic activity.
4. Amines and aminophenols
4-Ditnethylamino-3-l-hydroxydiphenyl, which is the ortho aminophenool corre-
sponding to 4-dimethylaminodiphenyl which had beeni shown to be carcinogenic
in rats (Miller, Miller, Sandill and Brown, 1949), gave all indefinlite result (2 tumours
in 13 mice).
2
2-Amiino-4: 5 dimlethylphenole
OH
d N(CH2
4 Dimethylamino-3-hydroxy diphenyl
0ON = H2
NH2
Pyridium
(2: 6-Diaiiino-3-pihenylazol)pyridine)
8- l[ydroxyq(ltinoline
N N (CH3)2
4-Di niethy,laiminoazobenzeno
(cH3)2NON =- N
0
3-(4'-Dilnethyvlaminophenyl )azol)yridine
N-oxide
Foirmulae C-Aiiines tand Ailiinophlenols
4-Dimethylaminoazobenzene or Butter Yellow is a liver carcinogen which was
inactive in the bladder. 2: 6-Diamino-3-phlenylazopyridine hydrochloride (Pyri-
dium) which is used asa urinary analgesic induced bladder tunmours. This compound
is similar to 3-(4'dimethylaminophenyl) azopyridine-N-oxide and other phenyl-
azopyridine derivatives which Brown, Malloy, McCarthy, Verrett and Cerecedo
(1954) found to be hepatic carcinogens, and is thus a heterocyclic analogue of
dimethylaminobenzene. Inthis compound, chelationispossiblethroughthe 2-amino
group and the azo linkage but dimethylaminoazobenzene which is not a bladder
carcinogen could be metabolised to a hydroxy-derivative with chelating properties.
2-Amino-4: 5-dimethylphenol (2-amino-4: 5-xylenol) is the simplest amino-
phenol found to be carcinogenic. Aminophenol itself and moniomethyl derivatives
are now being tested by the bladder implantation technique although Miller and
Miller (1948) found ortho aminophenol to be non-carcinogenic when tested by
feeding to rats.
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A number ofortho aminophenols are now known to induce cancer in the bladder
of mice and the problem of the mechanism of action presents itself. These amino-
phenols are very reactive compounds being readily oxidised and combining with
many reagents. They are also chelating agents forming complexes with metals
(Charles and Freiser, 1952). For this reason the active chelating agent, 8-hydroxy-
quinoline or oxine, was tested and gave tumours in 6 out of 16 mice which survived
30 weeks. Thus it is possible that this compound and the ortho aminophenols are
active by virtue of their chelating power. The activity might therefore be due to
combination of the carcinogen with the desoxyribonucleic acid (DNA) of chromo-
somes through the metals of the DNA forming a double chelate as a distorted
DNA molecule. Other possibilities are that the chelating agent competes with the
DNA molecules for metals which are probably essential for the correct functioning
of DNA of chromosomes or that they break nucleoprotein molecules as observed
by Kirby (1956) in vitro. On the other hand the fact that Bonser et al. (1954)
found 1-methoxy-2-naphthylamine induced bladder cancer in mice is not in
agreement with this hypothesis as this compound should be devoid of chelating
activity.
The carcinogenic action of 8-hydroxyquinoline is of practical interest because
this substance is used as a spermicidal agent in contraceptive preparations and
as a preservative particularly in tobacco in Germany (Wegner, 1955). Hoch-
Ligeti (1956) has described the induction of carcinoma of the vagina in rats
treated intravaginally with a contraceptive cream containing 8-hydroxyquinoline.
That there might be some relation between spermicidal and carcinogenic action is
perhaps not surprising as both effects are probably concerned with nuclear poison-
ing. In view ofthis and the result obtained with 8-hydroxyquinoline, a number of
spermicidal agents are being tested for carcinogenic activity in the vagina of
the mouse.
5 Tryptophan metabolites
The natural history of bladder cancer in men working with aromatic amines
does not differ from that of bladder cancer occurring iu the general population.
In the case of the occupational cancer the cause would seem to be the ortho
aminophenols liberated in the urine by the action of urinary ,8-glucuronidase on
excreted metabolites of aromatic amines such as 2-naphthylamine and 4-amino-
diphenyl. One might expect therefore that bladder cancer in the general popula-
tion is due to an excreted carcinogen. In normal metabolism in man and animals
tryptophan is converted to nicotinic acid by way of kynurenine, 3-hydroxy-
kynurenic and 3-hydroxy anthranilic acid; 3-hydroxykynurenine and 3-hydroxy-
anthranilic acid are ortho aminophenols and they are often present in human
urine. 2-Amino-3-hydroxyacetophenone is another ortho aminophenol derived
from tryptophan which is sometimes present in human urine (Dalgleish, 1955).
All these naturally-occurring ortho aminophenols induced bladder tumours in
our experiments.
Although pellets of 3-hydroxyanthranilic acid in cholesterol produced tumours,
pellets ofthe same compound in paraffin wax did not induce a significant number of
tumours (1 tumour in 22 mice). The diffusion of 3-hydroxyanthranilic acid from
pellets was therefore examined. The pellets were incubated in 1 ml. water at 38°.
After different intervals (indicated by the points in the figure) the aqueous phase
was replaced and the 3-hydroxyanthranilic acid estimated by measurement of
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TABLE I-COInt.
NH2
C H77Jy.2.CH2 COOH
H
Tryptoplian
NH2
~~~~I
COCH2CHCOOH
NH2
Kynuronine -.. -- Kynurenic acid
HO
>u77fy2CH2CH2NH2
H
5-HydroxytiyptaInine
NH2
Q, COCH2CHCOOH
NH2
OH
3 Ilydroxykynurenine
4
OH
'COOH
Xanthuienic acid
COCH3
QO NH2
OH
2-Amino-3-hydioxy acetophenone 3-Hydroxyantliranilic acid 8-Methoxy-4-hydroxyquinoline-
2-carboxylic acid
cH3 CH3
CO CO
>,,N ,NH2
3-Amino-4: 5-diacetyl-
phenoxazone (2)
2-Aminophenoxazone- 4 5-
dicarboxylic acid
Formulae D-Tryptophan Metabolites
n
b NACO{)H
OH
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the absorption at 298 mr/ in 0'1 N-HC1 solution using a Unicam Spectrophotometer.
The results (Fig. 2) show that the rate of diffusion of 3-hydroxyanthranilic acid
is such that about halfofthe 2-mg. of3-hydroxyanthranilic acid originally present
diffused out of a cholesterol pellet in 15 days and that about 10 per cent diffused
out in the first 24 hours. The rate of diffusion falls with time and varies so that
the diffusion at any time is proportional to the square ofthe amount of3-hydroxy-
anthranilic acid present at that time. On the other hand only 6 per cent of the
3-hydroxyanthranilic acid was detected in the water in which paraffin wax pellets
containing the acid had been incubated for 10 days.
J -0
Days
FIG. 2.-Release of 3-hydroxyanthranilic acid (3HAA) from (A) one cholesterol pellet containing
2 mg. 3HAA and (B) ten paraffin pellets each containing 2 mg. 3HAA.
Diffusion of the carcinogens withl urine in the bladders of the mice would
presumably occur at comparable rates and this could explain the apparent
inactivity of the 3-hydroxyanthranilic acid in paraffin wax pellets. The diffusion
of substances from paraffin wax must depend on the material first dissolving in
the continuous phase ofwax and then dissolving out with the surrounding water.
Diffusion out must therefore depend on solubility in wax and in water.
Diffusion from cholesterol pellets can proceed either by solution in the sterol
or by solution in water which penetrates between the crystals in the pellet. Polar
substances which are soluble in water are therefore likely to diffuse from the
compressed cholesterol pellets, but not from pellets ofparaffin wax. On the other
hand substances which are readily soluble in water may diffuse out of cholesterol
pellets too quickly, so that theyeither produce toxic effectsor are rapidlyexcreted.
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The inactivity of 2-amino-1-naphthol hydrochloride in the present experiments,
in contrast to the activity of this substance in paraffin wax found by Bonser
et al. (1956) might be due to the compound diffusing too rapidly from the
cholesterol pellets.
In view of these considerations the behaviour of different substances in pellets
should be studied and the appropriate medium-either paraffin wax, cholesterol
or other material chosen. The medium should allow the suspected carcinogen
to be released at a suitable rate.
In these experiments there is the possibility that the action is due to some
active impurity. Although attempts were made to use pure materials, many of
the substances used are unstable. Thus, 3-hydroxyanthranilic acid is easily
oxidised to 2-aminophenoxazone-4: 5-dicarboxylic acid acid (Butenandt, Biekert
and Neubert, 1957) and this might be a contaminant of the acid, Similarly
3-hydroxy-2-aminoacetophenone is readily oxidised to 3-amino-4: 5-diacetyl-
phenoxazone (2). These phenoxazones are similar in structure to the chromophore
of actinomycin and the amnochrome pigments of insects. Derivatives of this
type are under investigation for carcinogenic activity.
Plaine and Glass (1955) found that the addition of l-tryptophan indole or
anthranilic acid to thedietofDrosophilamelanogaster larvae produced an enormous
increase in the incidence of tumours in the larvae. The effect which was even
greater when the larvae were also exposed to oxygen at the same time, may be
connected withthe carcinogenic action oftryptophan metabolites inthe bladders of
mice.
Estimations ofthe excretionof 3-hydroxykynurenine and 3-hydroxyanthranilic
acid by human subjects has shown that men with cancer of the bladder excrete
more of these substances than do patients with other diseases (Boyland and
Williams, 1956). These aminophenols are probably excreted in urine in con-
jugated forms including the glucuronides and sulphuric esters which should,
however, behydrolysedby,8-glucuronidase orsulphatase intheurine, andtheurine
ofpatientswith cancerofthebladderusually containsabnormallyhigh/,-glucuroni-
dase and sulphatase activity (Boyland, Wallace and Williams, 1955).
The induction of bladder cancer in man by this mechanism is thus thought to
be dependent on the release of carcinogenic ortho aminophenols in urine from
inactive conjugated precursors by the action of enzymes. The effect can therefore
be expected to depend on (1) the concentration of the ortho aminophenol gluco-
siduronide, (2) the activity of f-glucuronidase and sulphatase in the urine and
(3) the time during which the urine remains in the bladder with enzymes acting
on the excreted aminophenol conjugates and liberating the carcinogenic ortho
aminophenols.
All these factors can be reduced unspecifically by increasing the water con-
sumption and so diluting the urine. The first factor can be reduced by avoiding
contact with aromatic amines or other precursors ofortho aminophenols or in some
cases by correcting the diet so that phenolic metabolites of tryptophan are not
excreted. The second or enzymic factor can be reduced by treatment with
1: 4-saccharolactone which is a potent inhibitor of/-glucuronidase (Levvy, 1952).
SUMMARY
(1) The operation for implantation of pellets into the bladders of mice has
been modified and used to test substances for their carcinogenic activity.INDUCED CANCER OF BLADDER IN MICE 227
(2) Xanthine and saccharin induced bladder tumours, but maleic hydrazide
did not under these conditions.
(3) Under conditions in which 1: 2-5: 6-dibenzanthracene gave bladder
tumours, 1: 2-5: 6-dibenzanthracene-3: 4-quinone and a metabolite of the
hydrocarbon, 2-phenylphenanthrene-2': 3-dicarboxylic acid did not induce
tumours, indicating that this metabolite is not concerned in carcinogenesis.
(4) Of the sixteen metabolites which have been identified in urine of animals
dosed with 2-naphthylamine, five have been tested in the mouse bladder and only
one of these, 2-amino-1-naphthol glucosiduronic acid gave tumours. This is in
agreement with knowledge of the behaviour of these substances.
(5) Of the simple aminophenols tested, 2-dimethylaminophenol and 2-amino-
4: 5-dimethylphenol produced tumours. 4-Dimethylaminoazobenzene (DAB)
did not induce tumours, but Pyridium (2: 6-diamino-3-phenylazopyridine) was
active.
(6) 8-Hydroxyquinoline, which like the ortho aminophenols is a chelating agent
(which is used as spermicide and fungicide) induced cancer in the mouse bladder.
(7) Three ortho aminophenols which are metabolites of tryptophan-2 amino
3-hydroxyacetophenone, 3-hydroxykynurenine and 3-hydroxy anthranilic acid
induced cancer on implantation in the bladders of mice. The possibility of such
compounds being the cause of cancer of the bladder in man is discussed.
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EXPLANATION OF PLATES
FIG. 3.-Papilloma from bladder of a mouse 40 weeks after implantation of cholesterol pellet
containing 2-amino-l-naphthol glucosiduronic acid. x 25.
FIG. 4.-Section of distended bladder from a mouse 40 weeks after implantation of cholesterol
pellet containing 2-amino-3-hydroxyacetophenonie. x 10.
FIG. 5.-Higher magnification of focus of carcinroma from bladder sholm in Fig. 4, showing
small invasive focus of carcinoma. x 40.
FIG. 6.-Section of bladder of a mouse killed 40 weeks after implantation of a cholesterol
pellet containing 3-hydroxyanthranilic acid showing solid differentiated carcinomna. x 11.
FIG. 7.-Section of bladder shown in Fig. 6. x 65.
FIG. 8.-Macroscopic view of the urinary bladder of a mouse killed 52 weeks following
implantation of 3-hydroxyanthranilic acid in cholesterol showing papillary carcinoma.
Four large carcinomatous lesions are seen projecting into the lumen of the bladder. x 3j.BRITISH JOURNAL OF CANCER. Vol. XI, No. 2.
L4 S .
Allen, Boyland, Dukes. Homing and Watson.
e-
t
i
t,
I
ABRITISH JOURNAL OF CANCER.
6 8
Allen, Boyland. Dukes, Horning and Watson.
Vol XI, No. 2.